
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PFE | NYSE | USD | Real-time | |
PFE | Mexico | MXN | Delayed | |
PFE | Stockholm | SEK | Real-time | |
PFE | Frankfurt | EUR | Delayed | |
PFE | TradeGate | EUR | Delayed | |
PFE | Hamburg | EUR | Delayed | |
PFE | Xetra | EUR | Delayed | |
PFE | Santiago | USD | Delayed | |
PFE | Buenos Aires | ARS | Delayed | |
PFIZ34 | BM&FBovespa | BRL | Delayed | |
PFE | Vienna | EUR | Delayed | |
PFE_KZ | KASE | USD | Delayed | |
PFE | Colombia | COP | Delayed | |
PFE | Lima | USD | Delayed |
For the three months ended 03 April 2022, Pfizer Inc. revenues increased 77% to $25.66B. Net income applicable to common stockholders excluding extraordinary items increased 61% to $7.87B. Revenues reflect Vaccines-Comimaty direct sales and alliance revenues segment increase from $3.46B to $13.23B, Hospital-Paxlovid segment increase from $0K to $1.47B, Developed Europe segment increase from $2.82B to $7.37B.
Period Ending: | Apr 03, 2022 | Dec 31, 2021 | Oct 03, 2021 | Jul 04, 2021 |
---|---|---|---|---|
Total Revenue | 25661 | 23635 | 24094 | 18977 |
Gross Profit | 15651 | 14024 | 14169 | 11991 |
Operating Income | 9873 | 4576 | 7647 | 5914 |
Net Income | 7863 | 3393 | 8146 | 5564 |
Period Ending: | Apr 03, 2022 | Dec 31, 2021 | Oct 03, 2021 | Jul 04, 2021 |
---|---|---|---|---|
Total Assets | 183841 | 181476 | 179188 | 169920 |
Total Liabilities | 101417 | 104276 | 103496 | 99878 |
Total Equity | 82424 | 77200 | 75692 | 70042 |
Period Ending: | Apr 03, 2022 | Dec 31, 2021 | Oct 03, 2021 | Jul 04, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 6541 | 32580 | 26666 | 15836 |
Cash From Investing Activities | 567 | -22546 | -19960 | -9884 |
Cash From Financing Activities | -6578 | -9816 | -6465 | -5364 |
Net Change in Cash | 529 | 159 | 209 | 593 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review